Latest News

California will make low-cost insulin, Gov. Newsom says


 

California Gov. Gavin Newsom says the state government will manufacture its own low-cost insulin to make the drug more affordable for residents.

On July 7, he said he had just signed a state budget that includes $50 million for development of the insulin and another $50 million for a place to make it.

“Nothing, nothing epitomizes market failures more than the cost of insulin,” Gov. Newsom said in a video posted on the governor’s Twitter page. He noted that many Americans have out-of-pocket costs ranging from $300 to $500 per month for insulin, which is used to treat diabetes.

“In California, we know people should not go into debt to receive lifesaving medication,” he said.

Gov. Newsom said that when he first took office, he signed an executive order to launch California’s own prescription drug system and that the insulin initiative is the first step toward making that happen.

People who take insulin have long complained about its high price. A November 2021 report from The Lancet said 25% of the insulin patients in the United States struggle to pay for it.

The cost of insulin for patients with insurance ranges from $334 to $1,000 a month, ABC News said, citing the Kaiser Family Foundation.

Legislation in Congress would bring down the cost of insulin if passed, with one bill capping costs at $35 per month for patients with health insurance. But The Hill reported that some Republicans oppose the legislation because it would interfere with free markets and raise costs for drug companies.

The CDC says 37.3 million people in the United States – about 11.3% of the population – have diabetes, with 8.5 million of them undiagnosed.

A version of this article first appeared on WebMD.com.

Recommended Reading

Could a type 2 diabetes drug tackle kidney stones?
MDedge Internal Medicine
iLet system simplifies insulin delivery for type 1 diabetes
MDedge Internal Medicine
Type 2 Diabetes and COVID-19
MDedge Internal Medicine
New data, film highlight islet cell transplantation progress
MDedge Internal Medicine
Type 1 diabetes control worse in racially segregated teens
MDedge Internal Medicine
Cardiologists concerned for patient safety after abortion ruling
MDedge Internal Medicine
Low-carb, high-fat diet improves A1c, reduces liver fat
MDedge Internal Medicine
Food insecurity drives poor glycemic control
MDedge Internal Medicine
Mobile devices ‘addictive by design’: Obesity is one of many health effects
MDedge Internal Medicine
‘Not their fault:’ Obesity warrants long-term management
MDedge Internal Medicine